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Resumen
De forma paralela al desarrollo de los aspec-
tos clínicos del asesoramiento en mujeres con
historia familiar de cáncer de mama, ha habido
una creciente necesidad de identificar las
secuelas psicológicas de averiguar el riesgo, el
examen genético y la cirugía profiláctica mama-
ria. La organización y la estructura de las Uni-
dades de Consejo Genético varían ampliamen-
te dentro del ámbito nacional y alrededor de
Europa, así como la integración en ellas de la
atención psicológica. La investigación disponi-
ble muestra poca variación en resultados psico-
sociales pero factores culturales afectan a las
actitudes, la realización del test genético y la
cirugía preventiva. Existe un acuerdo general en
que el consejo acerca del riesgo puede ser bene-
ficioso, sin que induzca o aumente la morbili-
dad psicológica. Los profesionales de la Salud
de los servicios de manejo de riesgo y test en
consejo genético oncológico usan cada vez más
protocolos clínicos y pautas profesionales. El
apoyo psicológico habitual no es necesario para
la mayoría de mujeres con una historia familiar
de cáncer de mama, pero el acceso a los servi-
cios psicológicos debe estar disponible para
aquellas mujeres que presenten un malestar ele-
vado debido a su historia familiar, o para aque-
llas que van a llevar a cabo un test genético o
cirugía preventiva. El personal de la Unidad de
consejo genético debe ser consciente de las con-
secuencias psicológicas adversas potenciales de
la evaluación del riesgo y de las intervenciones
para manejar el riesgo, y estar adecuadamente
entrenado para elicitar las preocupaciones de
las mujeres e implicar a los colegas psicosocia-
les cuando sea apropiado.
Palabras clave: Cáncer de mama, atención
psicológica, consejo genético, malestar.
Abstract
In parallel to the development of clinical
cancer genetics services for women with a
significant history of breast cancer, there has
been a growing need to identify the psycho-
logical sequelae to risk ascertainment, pre-
dictive genetic testing and preventive breast
surgery. The organisation and structure of
cancer genetics clinics vary widely both
nationally and across Europe, as does the
level of integration of psychological care:
available research shows little variation in
psychosocial outcomes but cultural factors
affect attitudes to and uptake of predictive
testing and preventive surgery. There is gene-
ral agreement that risk counselling can be
beneficial without inducing or increasing
psychological morbidity. Health professio-
nals in cancer genetic counselling, testing and
risk management services increasingly use
clinical protocols and professional guideli-
nes. Routine psychological support is not
required for the majority of women with a
family history of breast cancer, but access to
psychological services should be in place for
women with high distress relating to the
family history or those undergoing predictive
testing or preventive surgery. Genetics staff
should be aware of potential adverse psycho-
logical consequences of risk assessment and
risk management interventions, and be ade-
quately trained to elicit women’s concerns
and involve psychosocial colleagues where
appropriate.
Key words: Breast cancer, psychological
care, genetic counselling, distress.
INTRODUCTION
The field of breast cancer genetics has
been a rapidly growing one, and across
Europe this has prompted the development
of clinical cancer genetics services(1-3).
Much of the demand for information and
advice about familial breast cancer has
come from women themselves, wanting to
find out about the implications of their fami-
ly history and ways to manage the risk. 
Given the limited options for preventing
breast cancer, concern was expressed
about the potential for negative psycholo-
gical effects of providing detailed risk infor-
mation, especially if the actual risk was
much higher than the woman expected.
This motivated psychosocial research to
evaluate the impact of risk communication,
and studies in the UK drew on the experi-
ences of women attending family history
clinic services(4-6).
With the availability of testing for
breast cancer predisposing genes BRCA1
and BRCA2, research has determined the
uptake, psychological benefits and mor-
bidity consequent on predictive genetic
testing(7), highlighting issues for affected
and unaffected women. Results from large
prospective clinically based studies are
now available(8,9), providing longer-term
outcomes(9). The outcomes of decision-
making about preventive mastectomies
became a focus for investigation, given
the significant controversies around the
potential for benefit or harm with this pro-
cedure(10-12).
Psychological care for women at
increased risk of breast cancer has evolved
as evidence of need has accumulated, but
there has been wide variation in service pro-
vision and therefore in the structure and
organisation of psychological aspects of
cancer genetics services.  National guide-
lines and clinical protocols have now been
produced in a number of European coun-
tries(1,13,14) and so it is timely to review the
indications for psychological care in the
cancer genetics setting.
PSYCHOLOGICAL IMPACT OF RISK
COMMUNICATION: IMPLICATIONS
FOR CARE
A large literature now exists describing
the psychological impact of risk communi-
cation, in terms of levels of risk accuracy,
mental health and satisfaction, and results
have been further evaluated in systematic
reviews and meta-analyses(15-17). There is
still, however, a lack of information about
health behavioural consequences or
lifestyle changes. Risk knowledge and inaccu-
racies in women’s perceptions became a
focus for research when it was realised that
women had a hazy knowledge of their own
risks and of those in the general population.
Risks could be exaggerated or minimised,
and only 10% were accurate pre-coun-
selling. This improved to a sustained level
of 66% post-counselling in our own ser-
vice(18). Provision of personalised risk infor-
mation in a letter summarising the genetic
consultation  increased the accuracy of risk
perceptions following counselling(19). How-
ever, women who overestimated their risks
appear to be more refractory accurate risk
information and continued to hold inaccu-
rate risk perceptions. In turn, these were
found to be strongly associated with
increased cancer specific distress(20). Find-
ings are contradictory as to whether gene-
tic counselling reduces cancer worry(20,21),
but women with a dysfunctional level of
cancer worry may require psychological
support or intervention.
In order to better understand the nature
and aetiology of psychological morbidity in
women attending a family history clinic, we
carried out a longitudinal prospective study,
which involved in depth interviews and
serial questionnaire assessments. This gave
rich information about the psychological
support needs of these women(4). Results in
this clinical setting confirmed that the
majority of women experienced no increase
in psychological morbidity over the longer
term, so that routine psychological support
was not required. Prevalence of psycholo-
gical morbidity was equivalent to popula-
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tion rates and only about half of women
found to have psychiatric diagnoses at inter-
view needed or wanted psychological help.
Some women had unresolved grief relating
to the family history and disrupted family
life including sexual abuse in the family follo-
wing the death of a mother in childhood.
Other vulnerability factors are guilt because
of the chance of passing on the risk to
daughters and fear of the personal threat of
cancer, after witnessing the illness in a close
relative. Referral to psychological care may
be needed in these cases. Although research
studies have often been in agreement about
the prevalence of distress identified with
questionnaires, caution is needed in extra-
polating these results, as an indicator of 
support needs, as questionnaires are not
diagnostic and rates of distress may be
inflated. Threshold scores on scales used
may need to be re-calibrated to provide
more accurate results(4).
Facing the reality of the family history
and reviewing cancers in the generations
brought personal risk into focus for the first
time for some women, which was anxiety
provoking and upsetting, but usually only
transiently so(4). For those who experience
more acute distress at this time, prompt
access to psychological support is needed.
Psychological intervention may be required
for a prolonged period for a small number
of women for whom previously un
conscious losses and fears are evoked by
risk counselling.
IMPLICATIONS FOR GENETIC
COUNSELLING
Although it is assumed that the majority
of women attending cancer genetics services
want personal risk information, some women
feel the information is delivered unsympa-
thetically, and others received it even if it was
unwanted. It is important to ensure that
women’s reasons for attending a cancer
genetics clinic are elucidated routinely, so
that information and advice is appropriately
tailored(18,22). Issues of loss and grief may be
underestimated and psychological concerns
are often missed(23) in this setting. Genetic
counsellors need to be aware of the potential
to uncover such feelings during routine con-
sultations and to feel confident in discussing
them, and the importance of providing psy-
chosocial support around the process of
genetic testing has been well expressed in the
context of the genetic nursing role(24). More-
over a communication skills training was one
of the most valued components of genetics
nurse training programme(25) and this could
be made more routinely available. 
To date, surprisingly little research has
focussed on the process of risk communica-
tion itself, although an Australian group
have addressed this(23,26). The need for a
consensus for the definition of genetic
counselling and its goals has been elo-
quently argued in a recent review, and
strategies proposed for approaching this
complex area(27,28).  These authors promote
presentation of tailored information and a
more psychological focus. The need for
standardised information in a variety of for-
mats has also been highlighted.
IMPACT OF SERVICE
ORGANISATION ON
PSYCHOLOGICAL OUTCOMES
Referral rates, staffing level and compo-
sition of the multidisciplinary team within
cancer genetics services vary widely both
within countries(2) and across Europe(1).
Therefore psychological expertise, or
involvement of psychosocial staff in cancer
genetics clinics, is not routine or standar-
dised. In addition, there is considerable
variation in the design of service provision
nationally(2,29,30) and internationally(1): com-
parisons of different models of service pro-
vision services have attempted to determine
the psychological consequences of different
approaches and infer best practice for psy-
chological care. 
Findings are interesting and perhaps
counterintuitive. In the UK, it was antici-
pated that a model for service provision
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would be identified that could be used to
develop or refine other services, but no sin-
gle model has emerged. In a comparison of
risk counselling in S.E Scotland, existing
genetics services were compared with
community genetics clinics(29) whilst in
Wales, they were compared with surgical
clinics(30); results of both studies showed
no significant difference in psychosocial
outcomes. Moreover, in an evaluation of
psychosocial outcomes in randomly
selected UK cancer genetics centres, diffe-
rences in satisfaction with various aspects
of service provision were found, but these
could not be linked to any particular type
of clinical service(31), and no preferred
model could be identified. Centres differed
in the reduction of cancer worry reported
by counsellees, but these differences were
not clinically significant. In Europe, our
recent survey of seven centres found an
interesting balance between convergence
of aspects of clinical activity despite wide
divergence in national systems of medical
care and maturity of cancer genetics ser-
vices, indicating some standardisation of
aims and intentions, but psychosocial out-
comes were not available.
SPECIAL SITUATIONS
Genetic testing and preventive breast
surgery are two situations where the poten-
tial for psychological harm is arguably
greater because of the irreversible nature of
the information received or intervention
undertaken. Surgery in particular has been
a controversial issue both amongst medial
professionals as well as the lay public. 
Genetic testing
Availability and attitudes towards
genetic testing and preventive surgery vary
cross-culturally(32) but the psychological
consequences of predictive testing for
BRCA1/2 gene mutations has now been the
subject of some valuable research(8,9,33-35),
so that psychological support needs can be
more accurately estimated in this context
(see 7, and 36 for reviews). These studies
show psychological benefits in emotional
well being for women found to be non-
carriers and transient increases in distress
in carriers.  In the longer term, women with
gene mutations may have somewhat ele-
vated levels of cancer worry compared to
non-carriers, but these are not necessarily
increased over baseline levels. Younger
women may be more vulnerable to distress
and warrant closer monitoring. Where
women’s pre-test levels of distress are ele-
vated, monitoring is also advisable, as this
predicts post-test levels. However, raised
levels of general distress have not been
confirmed for the majority of women 
tested and carriers may feel more confident
making subsequent risk management deci-
sions. They value ensured access to breast
surveillance programmes, and relief of
long held uncertainty about their risk. All
women undertaking genetic testing should
be counselled about these costs and bene-
fits of the procedure; they should be made
aware of the potential for distress and of
the need for adaptation to carrier status.
Some may be unexpectedly distressed in
reaction to their results and warrant further
professional support. 
Whilst seeking genetic information for
family members may be a strong motiva-
tion for predictive genetic testing, other
women are distressed by the thought of
transferring a risk to their daughters. It has
become evident from recent literature that
disclosing such information in the family
may be upsetting and difficult. Apart from
the obvious problems of having to contact
estranged or little seen relatives, quite 
subtle factors may influence reactions to
disclosure, such as the order in which
results were obtained amongst siblings,
and the woman’s own expectations and
level of personal support. Genetic 
counselling can address particular hurdles
in transferring information through the
family, including the fact that some 
relatives may wish to avoid such informa-
tion, and that disclosure can change fa-
mily relationships. 
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Preventive surgery
Evidence exists for the reduction of risk
from preventive mastectomies and of the
potential for reduction in anxiety about can-
cer, but surgery has elicited very mixed
reactions across Europe, in terms of atti-
tudes and uptake, again based largely on
cultural differences. The stage of service
development and national funding for
health services also play a part.  There are
low uptake rates in France, for example,
whereas the UK and The Netherlands have
been active in providing surgical interven-
tion and evaluating its impact. A recent sys-
tematic review(37) concluded that there were
high levels of satisfaction with the decision
to undergo preventive mastectomies, but of
the psychosocial outcomes measured, body
image and feelings of femininity were the
most likely to cause dissatisfaction, espe-
cially if surgical complications occurred.
Emotional recovery was generally good and
reduced cancer worry was frequently
recorded. Despite the expected levels of risk
reduction, uptake of preventive mastecto-
my remains lower than for preventive
oophorectomy in most countries.
Manchester has an active programme of
cancer prevention, and our approach to risk
reducing beast surgery has been to inter-
vene on the basis of a strict clinical proto-
col(38), which requires extensive pre-opera-
tive counselling by a multidisciplinary
team. Specialist onco-plastic surgeons
undertake surgery and long-term follow-up
is a requirement. Psychological counselling
and assessment involves the partner 
wherever possible, and involves both a dis-
cussion of the woman’s own motivation,
expectations, and concerns about surgery,
as well as her perceived capacity to cope
with complications or disappointment,
should they arise. Past and present mental
health status and coping resources are dis-
cussed and intervention provided where
appropriate. Consultations are tailored to
individual circumstances to deal with per-
sonal concerns or vulnerability factors. The
protocol is flexible so that women may defer
surgery to deal with illness in the family, to
have further pregnancies or resolve rela-
tionship problems or cope with other 
priorities. Postoperative consultations
review progress at an early stage in order to
provide further advice and support if appro-
priate.
Clinical follow up data has now accu-
mulated in respect of psychosocial out-
comes(12,39) showing low levels of cancer
worry and body image concerns post ope-
ratively for the majority of women. A mean
reduction of cancer worry scores of 30%-
40% is observed over time, which is of
clinical value. Surgical complications can
have short and long term effects on psy-
chological well being and cosmesis, and
psychological support and intervention
may be required.  Both general psycholo-
gical support strategies, and pharmacolo-
gical intervention may be required for dis-
tressed women. Where body image con-
cerns result in avoidance behaviour, 
cognitive behaviour therapy or use of 
guided imagery may be very beneficial.
Women may need weeks or months to
accommodate the changes in their breasts
following reconstruction, and some say
that the breasts never quite feel like their
natural breasts. This does not cause regret
but is seen as an anticipated consequence
of risk reduction, which in itself can bring
substantial relief.  
Couples often need time to adapt to the
change in breast sensation and appearance
in the context of physical intimacy but sig-
nificant difficulties in sexual functioning
evoked by the procedure are not common.
In our experience, where there have been
pre-existing difficulties in a couple’s sex life
or the relationship itself, preventive surgery
can add an additional strain and may be
blamed for the problems. 
Data from other European centres have
reported the psychosocial outcomes of sur-
gery as well as the frequency and types of
complications associated with breast recons-
truction(40-42). Results emphasise the need to
adequately inform and discuss all aspects of
surgery realistically with women who are
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considering this approach. Only then can
they balance the advantages and disadvan-
tages in the context of their own priorities
and personal circumstances.
A specific concern that has arisen in our
preventive programme is the presentation of
women requesting mastectomies who have
factitious family histories of breast can-
cer(43), which could lead to inappropriate
surgery being undertaken. Although this is
uncommon, it is essential for clinical teams
to be alert to inconsistent family histories,
and to verify the family history of cancers
before agreeing to proceed.  
Finally, it is important to mention psy-
chological care needs for women affected
with cancer who carry a genetic mutation
or have a strong family history. It is beyond
the remit of this paper to discuss this in
detail, but it important to highlight the need
for good prospective studies, both qualita-
tive and quantitative, to tease out the inter-
play of complex decisions(44) and psycho-
logical issues(45-48) pertaining to their
predicament. 
SUMMARY
An extensive evidence base now exists
in which there are consistent findings in key
areas, so that psychosocial services within
cancer genetics can be developed accor-
ding to local resources and priorities. Psy-
chosocial counselling and information 
prior to predictive testing and preventive
surgery, delivered by a trained health pro-
fessional, should be available in cancer
genetics services. However, routine psy-
chological support for women at increased
risk is not necessary for the majority. There
may be a need for psychological assessment
and or intervention for women with psycho-
logical morbidity or unresolved grief, 
arising from the family history, and for those
women who have an unexpectedly difficult
reaction to predictive testing or preventive
surgery. Difficulties in adapting to surgical
outcomes or changes in sexual functioning
may affect a minority of couples and 
warrant further help. 
New areas of need for psychological
support are emerging as other aspects of can-
cer genetics are researched, such as difficul-
ties in disclosing risk information to family
members and problems concerning complex
decision-making for affected women. There-
fore cancer genetics service staff should be
aware of the potential for distress and aim to
build a multidisciplinary team skilled to pro-
vide optimal care, guided by clinical guide-
lines and protocols to support their interven-
tions, together with standard information
sources for their counsellees.
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